Cargando…

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report

Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuh, Michael J., Crosby, Sheena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401363/
https://www.ncbi.nlm.nih.gov/pubmed/36033110
http://dx.doi.org/10.24926/iip.v12i4.4034
_version_ 1784772952148934656
author Schuh, Michael J.
Crosby, Sheena
author_facet Schuh, Michael J.
Crosby, Sheena
author_sort Schuh, Michael J.
collection PubMed
description Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.
format Online
Article
Text
id pubmed-9401363
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-94013632022-08-25 Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report Schuh, Michael J. Crosby, Sheena Innov Pharm Clinical Experience Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401363/ /pubmed/36033110 http://dx.doi.org/10.24926/iip.v12i4.4034 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Experience
Schuh, Michael J.
Crosby, Sheena
Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title_full Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title_fullStr Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title_full_unstemmed Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title_short Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
title_sort conversion disorder in a pharmacogenomics, polypharmacy patient: case report
topic Clinical Experience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401363/
https://www.ncbi.nlm.nih.gov/pubmed/36033110
http://dx.doi.org/10.24926/iip.v12i4.4034
work_keys_str_mv AT schuhmichaelj conversiondisorderinapharmacogenomicspolypharmacypatientcasereport
AT crosbysheena conversiondisorderinapharmacogenomicspolypharmacypatientcasereport